Fig. 2
Durations of antiseizure treatment following acute symptomatic seizures. Durations of initial treatment with antiseizure medication (ASM; dark color) followed by time without antiseizure medication (bright color) in individual participants with acute symptomatic seizure of structural etiology (purple, n = 122) vs. non-structural etiologies (green, n = 19). Grey and black, ASM intake could not be determined because of loss to follow-up (FU) or death. Yellow rhombus, unprovoked seizure relapse. Black vertical lines, median durations of initial ASM treatment were 4.0 months in cases with structural etiology (n = 106) and 0 months in cases with non-structural etiology (n = 14)